Rajiv de Silva, President & COO at Valeant Pharmaceuticals International, Inc. (VRX), bought 6,180 shares at $40.40 ($250K) on 2011-08-12, disclosed to the SEC on 2011-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ENDP | BUY | 2015-11-12 | $500K | — | Filing → |
| VRX | SELL | 2012-11-09 | $4.1M | — | Filing → |
| VRX | SELL | 2012-11-08 | $12.0M | — | Filing → |